Big pharma chair Michel Demaré points to proxy advisors as cause of block on higher pay while more FTSE 100 companies plan boost to packages.

According to the High Pay Centre, there is scant evidence that paying executives more will help the economy and companies should grow talent.

Investors are likely to focus on top pay in this year’s AGM season, as research reveals that executive pay has bounced back.